Nicholas Alexander Feasey

Nicholas Alexander Feasey

Auto-generated profile, based on publicly available information

Nicholas Alexander Feasey

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in The Lancet
Verified
Journal Article
Open access
NFNicholas A Feasey
Nicholas A Feasey
GDGordon Dougan
Gordon Dougan
RKRobert Kingsley
Robert Kingsley
RHRobert S Heyderman
Robert S Heyderman
MGMelita A Gordon
Melita A Gordon
Invasive strains of non-typhoidal salmonellae have emerged as a prominent cause of bloodstream infection in African adults and children, with an associated case fatality of 20-25%. The clinical presentation of invasive non-typhoidal salmonella disease in Africa is diverse: fever, hepatosplenomegaly, and respiratory symptoms are common, and features of enterocolitis are often absent. The most important risk factors are HIV infection in adults, and malaria, HIV, and malnutrition in children. A distinct genotype of Salmonella enterica var Typhimurium, ST313, has emerged as a new pathogenic clade in sub-Saharan Africa, and might have adapted to cause invasive disease in human beings. Multidrug-resistant ST313 has caused epidemics in several African countries, and has driven the use of expensive antimicrobial drugs in the poorest health services in the world. Studies of systemic cellular and humoral immune responses in adults infected with HIV have revealed key host immune defects contributing to invasive non-typhoidal salmonella disease. This emerging pathogen might therefore have adapted to occupy an ecological and immunological niche provided by HIV, malaria, and malnutrition in Africa. A good understanding of the epidemiology of this neglected disease will open new avenues for development and implementation of vaccine and public health strategies to prevent infections and interrupt transmission.

1 June 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
TATrong T. Ao
Trong T. Ao
NFNicholas A. Feasey
Nicholas A. Feasey
MGMelita A. Gordon
Melita A. Gordon
KKKaren Helena Keddy
Karen Helena Keddy
FAFrederick J. Angulo
Frederick J. Angulo
JCJohn A. Crump
John A. Crump
Nontyphoidal Salmonella is a major cause of bloodstream infections worldwide, and HIV-infected persons and malaria-infected children are at increased risk for the disease. We conducted a systematic literature review to obtain age group–specific, population-based invasive nontyphoidal Salmonella (iNTS) incidence data. Data were categorized by HIV and malaria prevalence and then extrapolated by using 2010 population data. The case-fatality ratio (CFR) was determined by expert opinion consensus. We estimated that 3.4 (range 2.1–6.5) million cases of iNTS disease occur annually (overall incidence 49 cases [range 30–94] per 100,000 population). Africa, where infants, young children, and young adults are most affected, has the highest incidence (227 cases [range 152–341] per 100,000 population) and number of cases (1.9 [range 1.3–2.9] million cases). An iNTS CFR of 20% yielded 681,316 (range 415,164–1,301,520) deaths annually. iNTS disease is a major cause of illness and death globally, particularly in Africa. Improved understanding of the epidemiology of iNTS is needed.

11 May 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VWVanessa K Wong
Vanessa K Wong
SBStephen Baker
Stephen Baker
DPDerek J Pickard
Derek J Pickard
JPJulian Parkhill
Julian Parkhill
APAndrew Page
Andrew Page
GDGordon Dougan
Gordon Dougan

1 June 2015 in Vaccine
Verified
Journal Article
Closed access
SKSamuel Kariuki
Samuel Kariuki
MGMelita A. Gordon
Melita A. Gordon
NFNicholas Feasey
Nicholas Feasey
CPChristopher M. Parry
Christopher M. Parry

1 October 2017 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
PMPatrick Musicha
Patrick Musicha
JCJennifer E Cornick
Jennifer E Cornick
NBNaor Bar-Zeev
Naor Bar-Zeev
NFNeil French
Neil French
CMClemens Masesa
Clemens Masesa
NFNicholas A Feasey
Nicholas A Feasey
Bacterial bloodstream infection is a common cause of morbidity and mortality in sub-Saharan Africa, yet few facilities are able to maintain long-term surveillance. The Malawi-Liverpool-Wellcome Trust Clinical Research Programme has done sentinel surveillance of bacteraemia since 1998. We report long-term trends in bloodstream infection and antimicrobial resistance from this surveillance. In this surveillance study, we analysed blood cultures that were routinely taken from adult and paediatric patients with fever or suspicion of sepsis admitted to Queen Elizabeth Central Hospital, Blantyre, Malawi from 1998 to 2016. The hospital served an urban population of 920 000 in 2016, with 1000 beds, although occupancy often exceeds capacity. The hospital admits about 10 000 adults and 30 000 children each year. Antimicrobial susceptibility tests were done by the disc diffusion method according to British Society of Antimicrobial Chemotherapy guidelines. We used the Cochran-Armitage test for trend to examine trends in rates of antimicrobial resistance, and negative binomial regression to examine trends in icidence of bloodstream infection over time. Between Jan 1, 1998, and Dec 31, 2016, we isolated 29 183 pathogens from 194 539 blood cultures. Pathogen detection decreased significantly from 327·1/100 000 in 1998 to 120·2/100 000 in 2016 (p<0·0001). 13 366 (51·1%) of 26 174 bacterial isolates were resistant to the Malawian first-line antibiotics amoxicillin or penicillin, chloramphenicol, and co-trimoxazole; 68·3% of Gram-negative and 6·6% of Gram-positive pathogens. The proportions of non-Salmonella Enterobacteriaceae with extended spectrum beta-lactamase (ESBL) or fluoroquinolone resistance rose significantly after 2003 to 61·9% in 2016 (p<0·0001). Between 2003 and 2016, ESBL resistance rose from 0·7% to 30·3% in Escherichia coli, from 11·8% to 90·5% in Klebsiella spp and from 30·4% to 71·9% in other Enterobacteriaceae. Similarly, resistance to ciprofloxacin rose from 2·5% to 31·1% in E coli, from 1·7% to 70·2% in Klebsiella spp and from 5·9% to 68·8% in other Enterobacteriaceae. By contrast, more than 92·0% of common Gram-positive pathogens remain susceptible to either penicillin or chloramphenicol. Meticillin-resistant Staphylococcus aureus (MRSA) was first reported in 1998 at 7·7% and represented 18·4% of S aureus isolates in 2016. The rapid expansion of ESBL and fluoroquinolone resistance among common Gram-negative pathogens, and the emergence of MRSA, highlight the growing challenge of bloodstream infections that are effectively impossible to treat in this resource-limited setting. Wellcome Trust, H3ABionet, Southern Africa Consortium for Research Excellence (SACORE).

22 December 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GLGemma Langridge
Gemma Langridge
MFMaria Fookes
Maria Fookes
TCThomas R. Connor
Thomas R. Connor
TFTheresa Feltwell
Theresa Feltwell
NFNicholas Feasey
Nicholas Feasey
NTNicholas R. Thomson
Nicholas R. Thomson
Significance: Common features have been observed in the genome sequences of bacterial pathogens that infect few hosts. These “host adaptations” include the acquisition of pathogenicity islands of multiple genes involved in disease, losses of whole genes, and even single mutations that affect gene function. Within Salmonella enterica is a natural model system of four pathogens that are each other’s closest relatives, including a host-generalist, two host-specialists, and one with strong host associations. With whole-genome sequences, we aimed to improve our understanding of the number, nature, and order of these host adaptation events, shedding light on how human and animal pathogens arose in the past, and potentially allowing us to predict how emerging pathogens will evolve in the future.